A feed-forward regulatory loop in adipose tissue promotes signaling by the hepatokine FGF21 by Han, Myoung Souk et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
University of Massachusetts Medical School Faculty Publications 
2021-01-01 
A feed-forward regulatory loop in adipose tissue promotes 
signaling by the hepatokine FGF21 
Myoung Souk Han 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/faculty_pubs 
 Part of the Biochemical Phenomena, Metabolism, and Nutrition Commons, Cell Biology Commons, 
Cellular and Molecular Physiology Commons, Endocrine System Commons, Endocrinology Commons, 
and the Hormones, Hormone Substitutes, and Hormone Antagonists Commons 
Repository Citation 
Han MS, Perry RJ, Camporez J, Scherer PE, Shulman GI, Gao G, Davis RJ. (2021). A feed-forward 
regulatory loop in adipose tissue promotes signaling by the hepatokine FGF21. University of 
Massachusetts Medical School Faculty Publications. https://doi.org/10.1101/gad.344556.120. Retrieved 
from https://escholarship.umassmed.edu/faculty_pubs/1891 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in University of 
Massachusetts Medical School Faculty Publications by an authorized administrator of eScholarship@UMMS. For 
more information, please contact Lisa.Palmer@umassmed.edu. 
A feed-forward regulatory loop in adipose
tissue promotes signaling by the
hepatokine FGF21
Myoung Sook Han,1 Rachel J. Perry,2,3 João-Paulo Camporez,2,8 Philipp E. Scherer,4,5,6
Gerald I. Shulman,2,3 Guangping Gao,7 and Roger J. Davis1
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA;
2Department of Internal Medicine, 3Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven,
Connecticut 06520, USA; 4Touchstone Diabetes Center, 5Department of Internal Medicine, 6Department of Cell Biology,
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The cJun NH2-terminal kinase (JNK) signaling pathway is activated by metabolic stress and promotes the devel-
opment of metabolic syndrome, including hyperglycemia, hyperlipidemia, and insulin resistance. This integrated
physiological response involves cross-talk between different organs. Here we demonstrate that JNK signaling in
adipocytes causes an increased circulating concentration of the hepatokine fibroblast growth factor 21 (FGF21) that
regulates systemic metabolism. The mechanism of organ crosstalk is mediated by a feed-forward regulatory loop
caused by JNK-regulated FGF21 autocrine signaling in adipocytes that promotes increased expression of the adi-
pokine adiponectin and subsequent hepatic expression of the hormone FGF21. The mechanism of organ cross-talk
places circulating adiponectin downstream of autocrine FGF21 expressed by adipocytes and upstream of endocrine
FGF21 expressed by hepatocytes. This regulatory loop represents a novel signaling paradigm that connects autocrine
and endocrine signaling modes of the same hormone in different tissues.
[Keywords: autocrine; endocrine; FGF21; JNK; organ cross-talk]
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Fibroblast growth factor 21 (FGF21) is secreted by hepato-
cytes and circulates in the blood (Fisher andMaratos-Flier
2016; BonDurant and Potthoff 2018; Kliewer and Man-
gelsdorf 2019). This liver-derived hormone (hepatokine)
functions by binding receptors expressed by target tissues
formed by one of several FGF receptors together with the
coreceptor β-Klotho. It is established that FGF21 plays an
important role in the regulation of metabolism during the
initial phase of the starvation response by promoting he-
patic fatty acid oxidation and ketone body formation
(Fisher and Maratos-Flier 2016; Kliewer and Mangelsdorf
2019). The central nervous system represents a major tar-
get of FGF21 signaling by acting on receptors present in
the suprachiasmatic nucleus of the hypothalamus and
the dorsal vagal complex of the hindbrain (Bookout et al.
2013). These central actions of FGF21 include suppression
of physical activity and altered circadian behavior (Owen
et al. 2014), food choice preference (sugar and alcohol)
(Schumann et al. 2016; Talukdar et al. 2016; von Hol-
stein-Rathlou et al. 2016; Søberg et al. 2017), water
consumption (Song et al. 2018), protection from lipid-in-
duced liver and muscle insulin resistance (Camporez et
al. 2013), and increased sympathetic outflow from the
brainstem that promotes adipose tissue thermogenesis
and reduced body mass (Owen et al. 2014; Douris et al.
2015).
Hepatic Fgf21 gene expression is increased in response
to a wide array of nutritional stresses (Fisher and Mara-
tos-Flier 2016; BonDurant and Potthoff 2018; Kliewer
and Mangelsdorf 2019). Thus, Fgf21 gene expression is in-
creased by the nuclear hormone receptor PPARα in re-
sponse to starvation or consumption of a ketogenic diet
(Badman et al. 2007; Inagaki et al. 2007), by the transcrip-
tion factor ChREBP in response to simple sugars (Fisher
et al. 2017; Iroz et al. 2017), by the transcription factor
ATF2 in response to cold exposure (Hondares et al.
2011), and by the integrated stress response pathway8Present address:Department of Physiology, Ribeirao Preto School ofMed-
icine, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
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mediated by eIF2α/ATF4 and IRE1α/XBP1 in response to
ER stress, amino acid starvation, and mitochondrial dys-
function (Salminen et al. 2017).
The liver is the major source of the endocrine FGF21
that circulates in the blood and regulates energy expendi-
ture, glucose/lipid metabolism, and insulin sensitivity
(Markan et al. 2014; Vernia et al. 2016a), but muscle can
act also as an endocrine source of FGF21 in response tomi-
tochondrial myopathy (Tyynismaa et al. 2010). Interest-
ingly, pancreatic acinar cells secrete exocrine FGF21
that functions to maintain acinar cell proteostasis (Coate
et al. 2017). In contrast, adipocyte FGF21 functions pri-
marily in an autocrine/paracrine manner in response to
feeding/fasting cycles (Dutchak et al. 2012) and cold expo-
sure (Chartoumpekis et al. 2011; Hondares et al. 2011;
Fisher et al. 2012). These autocrine actions of FGF21
may be mediated, in part, by increased expression of the
coactivator PGC1α and the expression of thermogenic
genes (Fisher et al. 2012), increased PPARγ activity and in-
sulin sensitization (Dutchak et al. 2012), and increased ex-
pression of adipokines (Holland et al. 2013; Lin et al. 2013;
Huang et al. 2017). The absence of an endocrine function
for adipocyte FGF21may reflect expression levels and the
very short half-life of FGF21 in the blood (Fisher and Mar-
atos-Flier 2016; BonDurant and Potthoff 2018; Kliewer
and Mangelsdorf 2019).
The responsiveness of FGF21 to nutritional stress (Bon-
Durant and Potthoff 2018) is shared by the cJun NH2-ter-
minal kinase (JNK) signaling pathway (Sabio and Davis
2010). Indeed, JNK acts to suppress PPARα-induced hepat-
ic Fgf21 gene expression and promotes systemic insulin
resistance by reducing the amount of FGF21 circulating
in the blood (Vernia et al. 2014, 2016a). The observed insu-
lin resistance is characterized by decreased endocrine sig-
naling by FGF21 and reduced sympathetic tone, fatty acid
β-oxidation, energy expenditure, hyperglycemia, and hy-
perlipidemia (Owen et al. 2014; Douris et al. 2015). This
role of hepatic JNK to regulate endocrine expression of he-
patic FGF21 raises questions concerning the potential
function of JNK-regulated FGF21 expression by adipo-
cytes. We report that autocrine signaling by adipocyte
FGF21 triggers a feed-forward regulatory loop that pro-
motes endocrine FGF21 signaling by the liver. Thismech-
anism represents a novel signaling paradigm that
connects autocrine and endocrine signaling modes of
the same hormone in different tissues.
Results
JNK in adipose tissue promotes systemic diet-induced
insulin resistance
Weestablishedmicewith deficiency of JNK1 plus JNK2 in
adipocytes (Adipoq-Cre+/−Mapk8LoxP/LoxPMapk9LoxP/LoxP)
and Control mice (Adipoq-Cre+/−). Genotype analysis of
adipose tissue depots demonstrated Mapk8 and Mapk9
gene ablation in inguinal fat (IngF), epididymal fat (EpiF),
retroperitoneal fat (RetF), brown adipose tissue (BAT),
and isolated adipocyte fraction (ADF), but not in liver,
muscle, or the adipose tissue stromal vascular fraction
(SVF) (Supplemental Fig. S1A). Immunoblot analysis dem-
onstrated that JNK expression was decreased in the adipo-
cyte fraction, but not in the stromal vascular fraction, of
epididymal adipose tissue of JNK-deficient (ADKO) mice
compared with Control (ADWT) mice (Supplemental Fig.
S1B). These studies demonstrate an adipocyte-selective
defect in JNK expression in ADKO mice.
The mice were fed a chow diet (ND) or a high fat diet
(HFD) for 16 wk. No difference in total bodymass between
the ADWT mice and ADKO mice was detected (Fig. 1A,B).
However, JNK deficiency caused a reduction in adipose tis-
sue mass in HFD-fed mice (Supplemental Fig. S1C). Histo-
logical examination of white fat demonstrated that JNK
deficiency in adipocytes did not causemajor changes in ad-
ipose tissue morphology in ND-fed mice (Fig. 1D). In con-
trast, adipocyte size was reduced in the subcutaneous IngF
and BAT of ADKO mice compared with ADWT mice when
fedaHFD (Fig. 1D; SupplementalFig. S1D,E).Moreover, he-
patic steatosis of HFD-fed ADWT mice was suppressed in
HFD-fed ADKO mice (Fig. 1D; Supplemental Fig. S1F).
Gene expression analysis demonstrated increased ex-
pression of markers for macrophage infiltration (Adgre1)
in IngF of HFD-fed ADKO mice compared with ADWT
mice. Expression of markers for both M1-like (Cd11c)
and M2-like (Mgl1 and Mrc1) polarization were detected
in IngF of ADKO and ADWT mice (Supplemental Fig.
S2A,B). In contrast, similar expression levels of marker
genes for extracellular matrix remodeling (including
Col1α1, Mmp2, Mmp9, and Tgfβ1) were detected in IngF
of ADKO and ADKO mice (Supplemental Fig. S2C).
We found that consumption of a HFD caused hypergly-
cemia inADWTmice, but not inADKOmice (Fig. 1C). Glu-
cose tolerance tests demonstrated that feeding a HFD
caused glucose intolerance of ADWT mice, but not ADKO
mice (Fig. 1E; Supplemental Fig. S1G). Similarly, pyruvate
tolerance tests demonstrated that HFD consumption pro-
moted greater increases in plasma glucose concentrations
in ADWT mice compared with ADKO mice during a pyru-
vate tolerance test (Fig. 1F; Supplemental Fig. S1H).More-
over, insulin tolerance tests demonstrated that the HFD
feeding caused whole body insulin resistance in ADWT
mice, but not in ADKO mice (Fig. 1G; Supplemental Fig.
S1I). Collectively, these data indicate that HFD promotes
the development of insulin resistance in ADWT mice, but
not in ADKO mice.
To examine the impact of JNK deficiency on adipose in-
sulin signaling, we examined the activation of theAKT sig-
nalingpathwayby immunoblotanalysisusingantibodies to
AKT,pThr308-AKT, andpSer473-AKT.Similar insulin-stim-
ulated activation of AKT was detected in IngF and EpiF of
ND-fedADWTmice andADKOmice (Fig. 1H). ThisAKTac-
tivation in adipose tissuewas suppressed inHFD-fedADWT
mice, but insulin-stimulated AKT activation was detected
in HFD-fed ADKO mice (Fig. 1H). Similarly, insulin-stimu-
lated AKT activation was detected in the gastrocnemius
muscle of HFD-fed ADKO mice (Fig. 1H). These data indi-
cate that JNK in adipocytes impairs insulin signaling in
HFD-fed mice in adipose tissue and other tissues.
Studies of the circulating concentration of insulin dem-
onstrated that feeding a HFD caused hyperinsulinemia in
Han et al.
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ADWT mice, but not in ADKO mice (Fig. 2A). This reduc-
tion in hyperinsulinemiawas associated with suppression
of islet hypertrophy in the pancreas (Fig. 2B) and increased
glucose-stimulated insulin secretion (Fig. 2C,D). More-
over, the HFD-induced increase in the blood concentra-
tion of IL6 and leptin in ADWT mice was not detected in
ADKO mice (Fig. 2A).
Our analysis of ADWT and ADKO mice indicates that
JNK deficiency in adipocytes suppresses the development
of several hallmarks of insulin resistance in HFD-fedmice
(Fig. 1). To confirm this conclusion,we performed a hyper-
insulinemic-euglycemic clamp study (Fig. 2E–K). The glu-
cose infusion rate (a measure of whole body insulin
sensitivity) of ND-fed ADWT and ADKO mice was similar.
Consumption of a HFD by ADWT mice markedly reduced
the glucose infusion rate, consistent with the develop-
ment of insulin resistance (Fig. 2E,F). However, the
glucose infusion rate of HFD-fed ADKO mice was signifi-
cantly higher than HFD-fed ADWT mice (Fig. 2E,F). These
data demonstrate that adipocyte JNK deficiency did not
alter insulin sensitivity in ND-fed mice, but adipocyte
JNK deficiency strongly promoted insulin sensitivity in
HFD-fed mice. This increase in insulin sensitivity was as-
sociated with increased glycogen plus lipid synthesis (Fig.
2G) and reduced lipolysis, as monitored by a reduction in
circulating non-esterified fatty acids (NEFA) (Fig. 2H) and
reduced turnover of both glycerol and palmitate (Fig. 2I,J).
Moreover,HFD-fedADKOmice exhibited increasedwhole
body glucose uptake and increased glucose uptake by adi-
pose tissue and muscle compared with HFD-fed ADWT
mice (Fig. 2K). These data demonstrate that JNK defi-
ciency in adipocytes caused systemic protection against
the development of insulin resistance in HFD-fed mice.
JNK deficiency in adipocytes causes increased energy
expenditure
Metabolic cage analysis of gas exchange demonstrated
that JNK deficiency in adipocytes caused increased VO2,
VCO2, and energy expenditure (EE) in HFD-fed mice, but
changes in the respiratory exchange ratio (RER) were not
detected (Fig. 3A; Supplemental Fig. S2D). This increased
energy expenditure may contribute to the improved met-
abolic phenotype of HFD-fed ADKO mice compared with
HFD-fed ADWT mice (Figs. 1, 2). However, this increased
energy expenditure would be expected to cause decreased
body mass, which was not observed (Fig. 1A,B). It is most
likely that the bodymass is the consequence of a compos-
ite phenotype caused by a balance between the increased






B C Figure 1. HFD-induced metabolic syn-
drome is suppressed in mice with JNK defi-
ciency in adipocytes. (A) Whole body mass
of ND-fed and HFD-fed (16 wk) ADWT and
ADKO mice was measured (mean±SEM; n
=8∼9). (B) The fat mass and lean mass of
ND-fed and HFD-fed (16 wk) mice were
measured using 1H-MRS (mean±SEM; n=
8∼9). (C ) The blood glucose concentration
of ND-fed and HFD-fed (16 wk) mice was
measured (mean± SEM; n =8∼9). (∗∗∗) P<
0.001. (D) Sections prepared from ND-fed
and HFD-fed (16 wk) ADWT and ADKO
mice were stained with H&E. Scale bar,
100 µm. (E–G) Tolerance tests for glucose
(GTT), pyruvate (PTT), and insulin (ITT)
were performed using ND-fed and HFD-fed
(16 wk) mice (mean±SEM; n =7∼9). (∗) P<
0.05; (∗∗) P <0.01; (∗∗∗) P< 0.001. (H) ND-fed
and HFD-fed (16 wk) mice were treated
with insulin (15 min). Immunoblot analysis
was performed with extracts prepared from
adipose tissue (IngF and EpiF), liver, and gas-
trocnemius muscle using antibodies to
phospho-AKT, AKT, and αTubulin.
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consumption by HFD-fed ADKO mice compared with
HFD-fed ADWT mice (Supplemental Fig. S2E). The hyper-
leptinemia in HFD-fed ADWT mice, but not in HFD-fed
ADKO mice (Fig. 2A), may contribute to this difference
in feeding behavior and contribute to the improved meta-
bolic profile of HFD-fed ADKO mice compared with HFD-
fed ADWT mice (Zhao et al. 2020).
An expected consequence of increased energy expendi-
ture is a change in body temperature. We therefore mea-
sured core body temperature using telemetry with an
implanted probe and surface temperature by infrared pho-
tography. These studies demonstrated that the body tem-
perature of ADKO mice was increased compared with
ADWT mice (Fig. 3B). These data indicate that JNK defi-
ciency in adipocytes may cause increased adipose tissue
thermogenesis. Indeed, studies of IngF demonstrated in-
creased expression of a thermogenic gene signature and in-
creased expression of the thermogenic protein UCP1 (Fig.
3C,D) and an increase in PPAR-dependent gene expres-
sion (Fig. 3D).
Increased thermogenesis would be expected to provide
protection against reduced environmental temperature.
We therefore tested ND-fed ADWT and ADKO mice with
a chronic cold challenge (6°C) and measured core body
temperature. The ADKO mice maintained a significantly
higher body temperature than ADWT mice during 21 d of
cold exposure (Fig. 3E). Analysis of IngF tissue sections
demonstrated morphological evidence of adipose tissue
browning following cold exposure, including the presence
of small multilocular adipocytes (Fig. 3F). The cold-in-
duced browning of IngF in ADKO mice was greater than
ADWT mice based on adipose tissue morphology (Fig. 3F)
and expression of a browning gene signature (Fig. 3G).
Isothermal housing suppresses the metabolic phenotype
of mice with JNK deficiency in adipocytes
Increased thermogenesis may contribute to the improved
metabolic phenotype of HFD-fed ADKO mice compared
with HFD-fed ADWT mice. To test this hypothesis, we
housed mice under thermoneutral conditions (30°C). We
found that when housed at thermoneutrality, JNK defi-
ciency in adipocytes caused no significant change in
HFD-induced obesity (Supplemental Fig. S3A), hyper-
glycemia (Supplemental Fig. S3B), hyperinsulinemia
(Supplemental Fig. S3C) or the increased circulating con-
centrations of IL6 and leptin (Supplemental Fig. S3C).
The isothermal housing also suppressed the effects of
JNK deficiency in adipocytes on intolerance to glucose
and insulin (Supplemental Fig. S3D,E).
Analysis of inguinal adipose tissue sections demon-








Figure 2. Adipocyte JNK promotes insulin
resistance in HFD-fed mice. (A) The blood
concentration of insulin, IL6, and leptin
was measured by ELISA using ND-fed and
HFD-fed (16 wk) ADWT and ADKO mice
(mean±SEM; n=7∼8). (∗) P <0.05. (B) Pan-
creatic sections prepared from ND-fed and
HFD-fed (16 wk) ADWT and ADKO mice
were stained with DAPI and antibodies to
insulin and glucagon. Scale bar, 150 µm. Is-
let area was measured (mean±SEM; n=
6∼8). (∗∗∗) P< 0.001. (C,D) Glucose-stimu-
lated insulin secretion (GSIS) was measured
using ND-fed and HFD-fed (16 wk) ADWT
and ADKO mice (mean±SEM; n =7∼8). (∗)
P <0.05, (∗∗) P<0.01, (∗∗∗) P <0.001. (E–K )
Hyperinsulinemic-euglycemic clamp stud-
ies were performed using ND-fed and
HFD-fed (8 wk) ADWT and ADKO mice to
measure glucose infusion rate, glycogen
synthesis, nonesterified fatty acid (NEFA)
suppression, whole body glycerol turnover,
whole body palmitate turnover, whole
body glucose uptake, and glucose uptake
by EpiF and gastrocnemius muscle (mean±
SEM; n= 5∼7). (∗) P <0.05, (∗∗) P<0.01, (∗∗∗)
P <0.001.
Han et al.
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browning, including the presence of large unilocular adi-
pocytes, in both of ADWT and ADKO mice (Supplemental
Fig. S3F). Indeed, JNK deficiency caused only modest
changes in the expression of a browning gene signature
in the inguinal adipose tissue of mice housed under ther-
moneutral conditions (Supplemental Fig. S3G) compared
with mice at 21°C (Fig. 3D).
Together, these data demonstrate that the improved
metabolic phenotype of HFD-fed ADKO mice compared
with HFD-fed ADWT mice is caused, in part, by increased
thermogenesis caused by JNK deficiency in adipocytes.
JNK deficiency in adipocytes causes an increase in the
circulating concentration of FGF21
We have previously reported that JNK deficiency in hepa-
tocytes causes increased energy expenditure by promoting
hepatic Fgf21mRNA expression and increasing the circu-
lating concentration of FGF21 in the blood (Vernia et al.
2014, 2016a).We therefore investigated whether JNK defi-
ciency in adipocytes might also cause an increase in the
circulating concentration of FGF21. Indeed, HFD-fed
ADKO mice exhibited increased Fgf21 mRNA in adipose
tissue and an increased blood concentration of FGF21
compared with HFD-fed ADWT mice (Fig. 4A,B). These
changes were also detected at thermoneutrality (Supple-
mental Fig. S3H). The increased adipocyte Fgf21 mRNA
expression was associated with increased receptor expres-
sion in HFD-fed mice (Fgfr1 and Klb) (Fig. 4C,D; Supple-
mental Fig. S3I).
To test whether FGF21 contributed to the phenotype of
ADKO mice, we established Adipoq-Cre+/− Mapk8LoxP/LoxP
Mapk9LoxP/LoxP Fgf21LoxP/LoxP (ADKOΔFgf21) mice with a
deficiency of JNK1/2 plus FGF21 in adipocytes (Supple-
mental Fig. S4A). We found that the effect of JNK defi-
ciency in adipocytes to both increase the circulating
concentration of FGF21 and adipocyte Fgf21 mRNA ex-
pression was suppressed by adipocyte Fgf21 gene ablation
(Fig. 4A,B). Functional analysis demonstrated that
adipocyte Fgf21 gene ablation in ADKO mice prevented
HFD-induced hyperglycemia (Fig. 4E) and suppressed
thermogenesis (Fig. 4F). These data demonstrate that
JNK acts to suppress Fgf21 expression by adipocytes.
JNK in adipocytes regulates hepatic FGF21 expression
The finding that adipocyte Fgf21mRNA expression regu-
lates the circulating concentration of FGF21 (Fig. 4) was
unexpected because it has been previously established
that no FGF21 can be detected in the blood of mice with
Fgf21 gene ablation in hepatocytes (Markan et al. 2014;






Figure 3. JNK in adipocytes suppresses ad-
ipose tissue thermogenesis. (A) ND-fed and
HFD-fed (6 wk) ADWT and ADKO mice were
examined using metabolic cages to mea-
sure VO2, VCO2, respiratory exchange ratio
(RER), and energy expenditure (EE) (mean±
SEM; n= 8). (∗) P<0.05; (∗∗) P<0.01; (∗∗∗) P<
0.001. (B) Surface temperature was mea-
sured using infrared photography and core
body temperature was measured using an
implanted probe by telemetry (mean±
SEM; n =6∼12). (∗) P<0.05; (∗∗) P <0.01.
(C ) IngF sections of HFD-fed ADWT and
ADKO mice (16 wk) were stained with
DAPI and an antibody to UCP1. The
mean fluorescence intensity was measured
(mean±SEM; n =5). (∗) P <0.05. (D) RNA
isolated from the IngF of ND-fed and
HFD-fed (16 wk) ADWT and ADKO mice
was examined using TaqMan assays to
measure mRNA expression and presented
as a heat map (n= 6∼8). (E) The core body
temperature of ND-fed ADWT and ADKO
mice at 21°C (day 0) and at 6°C was mea-
sured using implanted probes by telemetry
(mean±SEM; n=10∼12). (∗) P <0.05; (∗∗) P
<0.01. (F ) IngF sections of ND-fed ADWT
and ADKO mice housed at 21°C and 6°C
(21 d) were stained with H&E. Representa-
tive sections are presented. Scale bar, 100
µm. (G) RNA isolated from the IngF tissue
of ADWT and ADKO mice housed at 6°C
(21 d) was examined using TaqMan assays
to measure mRNA expression and present-
ed as a heat map (n =6∼8).
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observation is that adipocyte FGF21 promotes expression
of hepatic FGF21. To test this hypothesis, we examined
hepatic Fgf21 expression in ADWT mice, ADKO mice,
and ADKOΔFgf21 mice. This analysis demonstrated that
JNK deficiency in adipocytes caused increased expression
of hepatic Fgf21 mRNA expression in HFD-fed ADKO
mice compared with HFD-fed ADWT mice (Fig. 4B) and
that this increase in hepatic Fgf21 mRNA expression
was suppressed by Fgf21 gene ablation in adipocytes
(Fig. 4B). These data demonstrate the presence of a feed-
forward loop that is initiated by JNK-regulated Fgf21 ex-
pression in adipocytes that promotes Fgf21 expression
by hepatocytes to increase the circulating concentration
of FGF21 in the blood.
To test the role of hepatic FGF21, we ablated the Fgf21
gene in the hepatocytes of ADWT mice, ADKO mice, and
ADKOΔFgf21 mice by tail vein administration of AAV8-
TBG-Cre (Supplemental Fig. S5A). FGF21 receptor expres-
sion (Fgfr1 andKlbmRNA) was detected in adipose tissue
and the liver (Fig. 5A,B). Ablation of the hepatocyte Fgf21
gene prevented the increased circulating FGF21 concen-
tration detected in mice with JNK deficiency in adipo-
cytes (Fig. 5C,D). This observation confirms that the
circulating FGF21 in mice with JNK deficiency in adipo-
cytes is secreted by the liver.
We found that hepatic Fgf21 gene ablation did not affect
body mass (Supplemental Fig. S5B,C). Nevertheless, the
improved tolerance to glucose and pyruvate caused by
JNK deficiency in adipocytes was suppressed by hepatic
Fgf21 gene ablation in HFD-fed mice (Fig. 5E,F; Supple-
mental Fig. S5D,E). Similarly, the improved insulin toler-
ance caused by adipocyte JNK deficiency was reversed by
hepatic Fgf21 gene ablation inHFD-fedmice (Fig. 5G; Sup-
plemental S5F). We also found that hepatic Fgf21 gene ab-
lation suppressed the effect of adipocyte JNK deficiency to
reduce HFD-induced hyperglycemia (Fig. 5H) and hyper-
insulinemia (Fig. 5I). Hepatic Fgf21 gene ablation also sup-
pressed the effect of adipocyte JNK deficiency to decrease
hepatic steatosis (Fig. 5J) and promote adipocyte browning
(Fig. 5J,K). These data indicate that hepatic FGF21 is im-
portant for the metabolic actions of JNK in adipocytes.
Adipose signaling to the liver increases FGF21 circulating
in the blood
Adipose signaling to the liver is physiologically important
and may be mediated by several different mechanisms
(Titchenell et al. 2017; Petersen and Shulman 2018;
Funcke and Scherer 2019). For example, it has been pro-
posed that adipose tissue lipolysis generates fatty acids
that can activate the hepatic PPARα nuclear hormone re-
ceptor and increase FGF21 expression by the liver (Chen
et al. 2011). Since ADKO mice display reduced adipose tis-
sue lipolysis compared with ADWT mice (Fig. 2H–J), it ap-
pears unlikely that thismechanism contributes to adipose
tissue cross-talk to the liver in ADKO mice. A second po-
tential mechanism is represented by the adipokine IL6
(Sabio et al. 2008; Stanford et al. 2013) that circulates in
the blood of HFD-fed ADWT mice and is suppressed in




Figure 4. FGF21 mediates the metabolic
actions of JNK signaling in adipocytes. (A)
The blood concentration of FGF21 in ND-
fed and HFD-fed (16 wk) ADWT, ADKO,
and ADKOΔFgf21 mice was measured by
ELISA (mean±SEM; n =6∼8). (∗) P <0.05;
(∗∗) P< 0.01; (∗∗∗) P<0.001. (B–D) The ex-
pression of Fgf21, Fgfr1, and Klb by IngF
and liver was measured by TaqMan assays
(mean± SEM; n=6∼8). (∗) P<0.05; (∗∗) P <
0.01; (∗∗∗) P<0.001. (E) The fasted blood glu-
cose concentration was measured (mean±
SEM; n= 6∼8). (∗∗) P <0.01. (F ) Surface tem-
perature was measured using infrared pho-
tography (mean±SEM; n=8∼14). (∗∗) P<
0.01; (∗∗∗) P<0.001.
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appears unlikely because it has recently been demonstrat-
ed that adipocyte-derived IL6 does not cause changes in
systemic insulin resistance (Whitham et al. 2019; Han
et al. 2020). We also considered a third potential mecha-
nism of adipose to liver cross-talk that involves exo-
some-mediated microRNA delivery from adipose tissue
to the liver to regulate hepatic Fgf21 expression (Thomou
et al. 2017). Indeed, we found reduced adipocyte expres-
sion of microRNAs that may target Fgf21 mRNA (miR-
99a, miR-99b-5p, miR-99b-3p, and miR-100) in adipose
tissue of ADKO mice compared with ADWT mice (Supple-
mental Fig. S4B). This reduction in adipocyte microRNA
expression was not detected in ADKOΔFgf21 mice (Supple-
mental Fig. S4B); this finding implicates FGF21 in the sup-
pression of these microRNAs in adipose tissue. However,
no significant difference in the hepatic expression of these
microRNAs between ADKO and ADWT mice was detected
(Supplemental Fig. S4B). These microRNAs therefore do
notmediate the effects of adipocyte JNK deficiency on he-
patic Fgf21 mRNA expression. A different mechanism
must therefore account for adipose tissue cross-talk to
the liver in ADKO mice.
It is established that FGF21 increases adiponectin ex-
pression by activating PPARγ (Holland et al. 2013; Lin
et al. 2013) and that JNK acts to suppress adiponectin ex-
pression (Manieri et al. 2019). Indeed, treatment of mice
with recombinant FGF21 caused increased Adipoq and
Fgf21 gene expression by adipose tissue (Supplemental
Fig. S6A). We therefore examined Adipoq mRNA expres-
sion and the circulating concentration of adiponectin in
ADWT andADKOmice.We found thatmicewith JNK defi-
ciency in adipocytes expressed increased amounts of Adi-
poq mRNA and exhibited a higher concentration of
circulating adiponectin in the blood (Fig. 6A,B). These
changeswere disrupted by ablation of the Fgf21 gene in ad-
ipocytes (Fig. 6A,B). In contrast, ablation of the Fgf21 gene
in hepatocytes using AAV8-TBG-Cre did not prevent the
effect of adipocyte JNK deficiency to increase adipose tis-
sue expression of AdipoqmRNA and the circulating con-
centration of adiponectin (Fig. 6C,D). These data indicate
that autocrine/paracrine signaling by adipocyte FGF21
promotes the expression of adiponectin.
Adiponectin may mediate cross-talk between adipose
tissue and the liver (Straub and Scherer 2019). We found
that treatment with adiponectin caused increased Fgf21
gene expression in cell culture (Supplemental Fig. S6B).
To test whether adiponectin contributes to the phenotype







B C D Figure 5. Hepatic FGF21 is required for the
metabolic actions of JNK signaling in adipo-
cytes. (A–C ) ADWT, ADKO, and ADKOΔFgf21
mice were treated with AAV8-TBG-Cre
and fed a HFD (16 wk). The expression of
Fgf21, Fgfr1, and Klb by IngF and liver was
measured by TaqMan assays (mean± SEM;
n =5∼8). (∗) P< 0.05; (∗∗) P <0.01. (D) The
blood concentration of FGF21wasmeasured
by ELISA (mean±SEM; n =6∼7). (∗∗) P<
0.01; (∗∗∗) P<0.001. (E–G) Tolerance tests
for glucose (GTT), pyruvate (PTT), and insu-
lin (ITT) were performed (mean± SEM; n=
6∼7). (∗) P<0.05; (∗∗) P < 0.01; (∗∗∗) P<
0.001. (H) The fasted blood glucose concen-
tration was measured (mean±SEM; n=
6∼7). (∗∗) P<0.01. (I ) The blood concentra-
tion of insulin was measured by ELISA
(mean±SEM; n =6∼7). (∗) P <0.05; (∗∗) P<
0.01. (J) Sections prepared from IngF and liv-
er were stained with H&E. Scale bar, 100
µm. (K ) RNA isolated from IngF was exam-
ined using TaqMan assays to measure
mRNA expression and presented as a heat
map (n=6∼8).
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Mapk9+/+ Adipoq−/− (ADWTΔAdq) mice with adiponectin
deficiency and Adipoq-Cre+/− Mapk8LoxP/LoxP Map-
k9LoxP/LoxP Adipoq−/− (ADKOΔAdq) mice with deficiency
of adiponectin plus JNK1/2 in adipocytes. No adiponectin
in the blood of ADWTΔAdq and ADKOΔAdq mice was detect-
ed. We found that adipocyte JNK deficiency in adiponec-
tin-deficient mice did not increase hepatic Fgf21 mRNA
expression or the circulating concentration of FGF21
(Fig. 6E,F). FGF21 receptor expression (Fgfr1 and Klb
mRNA) was detected in adipose tissue and the liver (Fig.
6G,H). Moreover, adipocyte JNK deficiency did not alter
bodymass (Fig. 6I), resistance to cold stress (Supplemental
Fig. S7), tolerance to glucose or insulin (Fig. 6J,K; Supple-
mental Fig. S8A,B), hyperglycemia (Fig. 6L), adipocyte
morphology or hepatic steatosis (Fig. 6M) in adiponec-
tin-deficient mice. These data indicate that adiponectin
is required for the effect of adipocyte JNK deficiency to in-
crease hepatic Fgf21 mRNA expression and the circulat-
ing concentration of FGF21.
Endocrine signaling by hepatic FGF21 does not require
adiponectin
It is established that adiponectin contributes to the re-
sponse ofmice to treatmentwith recombinant FGF21 (Hol-
land et al. 2013; Lin et al. 2013). We therefore tested
whether adiponectin is required for the endocrine function
of endogenous FGF21. We have reported that JNK defi-
ciency in hepatocytes causes increased hepatic Fgf21
mRNA expression and an increased circulating concentra-
tion of FGF21 (Vernia et al. 2014).Moreover, hepatic FGF21
expression is required for the effects of hepatocyte JNKdefi-
ciency onmetabolism (Vernia et al. 2016a). To test the role
of adiponectin, we established Alb-Cre+/− Mapk8+/+
Mapk9+/+ Adipoq−/− (AlbWTΔAdq) mice with adiponectin
deficiency and Alb-Cre+/− Mapk8LoxP/LoxP Mapk9LoxP/LoxP
Adipoq−/− (AlbKOΔAdq) micewith deficiency of adiponectin
plus JNK1/2 in hepatocytes. No adiponectin was detected
in the blood of AlbWTΔAdq and AlbKOΔAdq mice.
We found that adiponectin deficiency did not prevent
the effect of hepatocyte JNK deficiency to increase hepatic
Fgf21 mRNA expression or the circulating concentration
of FGF21 (Fig. 7A,B). These data demonstrate that adipo-
nectin is not required for hepatic FGF21 expression.More-
over, FGF21 receptor expression (Fgfr1 and Klb mRNA)
was detected in adipose tissue and the liver (Fig. 7C,D).
To test whether adiponectin is required for hepatic
FGF21 function, we characterized the metabolic pheno-
type ofHFD-fedAlbWTΔAdq andAlbKOΔAdqmice.We found
that JNK deficiency in hepatocytes decreased body fat
mass (Fig. 7E,F), suppressed HFD-induced hyperglycemia







B C D Figure 6. Endocrine FGF21 secreted by the
liver is required for the metabolic actions of
JNK signaling in adipocytes. (A,B) ADWT,
ADKO, and ADKOΔFgf21 mice were fed a
HFD (16 wk). The circulating concentration
of adiponectin was measured by ELISA
(mean± SEM; n =7∼8). (∗∗) P <0.01. The ex-
pression ofAdipoqmRNAby IngFwasmea-
sured by TaqMan assay (mean±SEM; n=7).
(∗) P< 0.05; (∗∗) P<0.01. (C,D) Mice were
treated with AAV8-TBG-Cre and fed a HFD
(16 wk). The circulating concentration of
adiponectin was measured by ELISA (mean
±SEM;n =6). (∗)P <0.05; (∗∗)P<0.01. The ex-
pression ofAdipoqmRNAby IngFwasmea-
sured by TaqMan assay (mean± SEM; n=
6∼7). (∗∗) P< 0.01. (E) The blood concentra-
tion of FGF21 in ND-fed and HFD-fed (16
wk) ADWTΔAdq and ADKOΔAdq mice was
measured by ELISA (mean±SEM; n =6∼10).
(F–H) The expression of Fgf21, Fgfr1, and
Klb by IngF and liver was measured by Taq-
Man assays (mean± SEM; n =6∼8). (∗∗) P <
0.01. (I ) Whole body mass of ND-fed and
HFD-fed (16 wk) mice was measured (mean
±SEM; n =6∼11). (J,K ) Tolerance tests for
glucose (GTT) and insulin (ITT) were per-
formed using ND-fed and HFD-fed (16-wk)
mice (mean±SEM; n=8∼11). (L) The fasted
blood glucose concentration was measured
(mean± SEM; n= 8∼11). (M ) Sections pre-
pared from IngF and liver were stained with
H&E. Scale bar, 100 µm.
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insulin in HFD-fed mice (Fig. 7H–J; Supplemental Fig.
S8C–E), increased core body temperature in HFD-fed
mice (Fig. 7K), reduced hepatic steatosis and increased ad-
ipose browning (Fig. 7L). Together, these data indicate
that adiponectin is not required for the biological actions
of endocrine FGF21. It is likely that these actions of
FGF21 are mediated, in part, by a central mechanism, in-
cluding an increase in sympathetic nervous system out-
flow (Fisher and Maratos-Flier 2016; BonDurant and
Potthoff 2018; Kliewer and Mangelsdorf 2019).
Discussion
Amajor target of endocrine FGF21 signaling is the central
nervous system, including the suprachiasmatic nucleus of
the hypothalamus and the dorsal vagal complex of the
hindbrain (Bookout et al. 2013). FGF21 causes behavioral
changes (Bookout et al. 2013) and increases sympathetic
outflow from the brain (Owen et al. 2014; Douris et al.
2015). This sympathetic outflow causes increased energy
expenditure by stimulation of brown adipose tissue and
promotion of white adipose tissue “browning,” increased
glucose uptake, reduced blood glucose and lipid concen-
trations, and increased insulin sensitivity (Camporez
et al. 2013; Fisher and Maratos-Flier 2016; BonDurant
and Potthoff 2018; Kliewer and Mangelsdorf 2019). The
importance of FGF21 signaling in the brain was estab-
lished by examination of mice with neuron-specific defi-
ciency of the obligate coreceptor β-Klotho. These studies
demonstrated that neuronal FGF21 signaling is essential
for the chronic metabolic actions of FGF21 (Owen et al.
2014; Lan et al. 2017). Similar studies of mice with β-Klo-
tho deficiency in adipocytes demonstrated that FGF21 sig-
naling in adipose tissue can mediate acute metabolic
actions of FGF21, including increased adipose tissue glu-
cose uptake (BonDurant et al. 2017; Lan et al. 2017). In
contrast, no requirement for hepatic FGF21 signaling
was detected (Lan et al. 2017). The physiological response
to FGF21 is therefore mediated primarily by the central
nervous system, but adipocytes contribute to FGF21 met-
abolic responses.
The liver is the major source of the endocrine FGF21
that circulates in the blood (Markan et al. 2014; Vernia
et al. 2016a). Adipocyte FGF21 functions primarily in an
autocrine/paracrinemanner in response to feeding/fasting
cycles (Dutchak et al. 2012) and cold exposure (Chartoum-
pekis et al. 2011; Hondares et al. 2011; Fisher et al. 2012).
These autocrine actions of FGF21 may be mediated, in
part, by increased expression of the coactivator PGC1α
(Fisher et al. 2012) and increased PPARγ activity (Dutchak







B C D Figure 7. Adiponectin is not required for endo-
crine signaling by FGF21. (A) AlbWTΔAdq and
AlbKOΔAdq mice were fed a HFD (16 wk). The
blood concentration of FGF21 was measured
by ELISA (mean±SEM; n=7∼8). (∗) P<0.05;
(∗∗∗) P<0.001. (B–D) The expression of Fgf21,
Fgfr1, and Klb by IngF and liver was measured
by TaqMan assays (mean±SEM; n=7∼8). (∗)
P <0.05; (∗∗) P<0.01; (∗∗∗) P<0.001. (E,F ) The
body weight was measured (mean±SEM; n=
7∼10). Fat mass and lean mass were measured
by 1H-MRS analysis (mean±SEM; n=7∼10).
(∗∗) P<0.01. (G) The fasted blood glucose con-
centration was measured (mean±SEM; n=
7∼10). (∗∗∗) P<0.001. (H–J) Tolerance tests for
glucose (GTT), pyruvate (PTT), and insulin
(ITT) were performed using ND-fed and HFD-
fed (16-wk) mice (mean±SEM; n=7∼10). (∗) P<
0.05; (∗∗) P<0.01; (∗∗∗) P<0.001. (K ) Core body
temperature was measured using an implanted
probe by telemetry (mean±SEM; n=7∼8). (∗∗)
P<0.01. (L) Sections prepared from IngF and liv-
er were stained with H&E. Scale bar, 100 µm.
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include increased glucose uptake and insulin sensitivity
(BonDurant et al. 2017; Lan et al. 2017), and increased ex-
pression of adipokines (Holland et al. 2013; Lin et al. 2013;
Huang et al. 2017).
Role of FGF21 in the metabolic stress response to JNK
activation
The JNK signaling pathway is activated by nutritional
stress and is associated with the development of hall-
marks of metabolic syndrome (Davis 2000; Sabio and Da-
vis 2010). The major effects of JNK on obesity are
mediated by hypothalamic signaling to regulate energy
expenditure by JNK1/2 (Belgardt et al. 2010; Sabio et al.
2010a; Vernia et al. 2013) and satiety by JNK3 (Vernia
et al. 2016b). Insulin resistance requires the actions of
JNK in the innate immune system (Han et al. 2013) and
also peripheral insulin target tissues (liver, muscle, and
adipose tissue) (Sabio et al. 2008, 2010b; Sabio and Davis
2010; Vernia et al. 2014; Perry et al. 2015). Studies of he-
patic JNK signaling demonstrate that JNK suppresses
PPARα-mediated Fgf21 gene expression and endocrine
secretion of FGF21 (Vernia et al. 2014). Ablation of the
Fgf21 gene in hepatocytes is sufficient to suppress the ef-
fects of JNK deficiency in hepatocytes on resistance to the
development of metabolic syndrome (Vernia et al. 2016a).
This observation demonstrates that FGF21 represents an
important mediator of hepatic JNK signaling that can sys-
temically regulate metabolism.
Herewe report that JNK signaling in adipocytes can also
systemically regulate metabolism by regulating hepatic
FGF21 expression. The hormone FGF21 therefore plays a
key role in the metabolic actions of JNK. This hormonal
function of hepatic FGF21 regulates systemicmetabolism
(Fisher and Maratos-Flier 2016; BonDurant and Potthoff
2018; Kliewer andMangelsdorf 2019). An important focus
for future studies will be to identify FGF21-independent
mechanisms that also contribute to metabolic stress sig-
naling by JNK in adipocytes.
Cross-talk between adipose tissue and the liver
Substantial evidence links adipose tissue to the regulation
of hepatic metabolism (Titchenell et al. 2017; Petersen
and Shulman 2018; Funcke and Scherer 2019). For exam-
ple, insulin-regulated adipose tissue lipolysis contributes
to hepatic glucose production (Perry et al. 2015; Titche-
nell et al. 2016). Our study of JNK signaling in adipocytes
provides another example of adipose tissue cross-talkwith
the liver.
We show that reduced JNK signaling in adipocytes pro-
motes FGF21 expression and increases autocrine/para-
crine FGF21 signaling. PPARγ activation by FGF21 in
adipocytes increases Adipoq mRNA expression and in-
creases the concentration of adiponectin circulating in
the blood (Holland et al. 2013; Lin et al. 2013). Subsequent
adiponectin binding to hepatic receptors (AdipoR2) causes
PPARα activation in hepatocytes (Yamauchi et al. 2007;
Ishtiaq et al. 2019) thatmay promote Fgf21mRNAexpres-
sion and endocrine secretion of FGF21 (Badman et al.
2007; Inagaki et al. 2007). This mechanism indicates
that autocrine/paracrine signaling by adipocyte FGF21
triggers a feed-forward loop that promotes endocrine
FGF21 signaling by the liver (Fig. 8). This signaling para-
digm provides new insight into the complexity of adipose
tissue cross-talk with the liver.
Adiponectin plays an important role in organ cross-talk
by mediating a connection between autocrine/paracrine
FGF21 signaling by adipocytes and endocrine FGF21 sig-
naling by hepatocytes. Adiponectin functions down-
stream from adipocyte FGF21 and upstream of hepatic
FGF21. Consequently, endocrine signaling by hepatic
FGF21 is independent of adiponectin. Adiponectin is
therefore a keymediator of autocrines/paracrine signaling
by adipocyte FGF21 because adiponectin can promote en-
docrine expression of FGF21 by the liver.
Conclusions
This study identifies a mechanism for organ cross-talk
that is initiated by JNK-regulated FGF21 expression in ad-
ipose tissue. Autocrine/paracrine signaling by adipocyte
FGF21 increases the circulating concentration of adipo-
nectin that promotes expression of the hormone FGF21
by the liver. This feed-forward regulatory loop represents
a novel signaling paradigm that connects autocrine and




Key resources are listed in Supplemental Table S1.
Mice
C57BL/6J mice (RRID: IMSR_JAX:000664), B6;FVB-Tg(Adipoq-
Cre)1Evdr mice (RRID: IMSR_JAX:028020) (Eguchi et al. 2011),
and B6.Cg-Speer6-ps1Tg(alb-cre)21Mgn/J mice (RRID: IMSR_
Figure 8. Schematic illustration of organ cross-talk by autocrine
FGF21 signaling by adipocytes and endocrine signaling by the
liver.
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JAX:003574) (Postic et al. 1999) were obtained from The Jackson
Laboratory. We have previously described Adipoq−/− mice
(Nawrocki et al. 2006), Fgf21LoxP/LoxP mice (Vernia et al. 2016a),
Mapk8LoxP/LoxP mice (Das et al. 2007), and Mapk9LoxP/LoxP mice
(Han et al. 2013). The mice were backcrossed to the C57BL/6J
strain (10 generations) and housed in a specific pathogen-free fa-
cility accredited by the American Association for Laboratory An-
imal Care using laminar flow cages at 21°C. Mice were housed at
thermoneutrality (30°C) in the vivarium using rodent incubators
(Powers Scientific, Inc. model RIT33SD). Cold exposure was per-
formed by reducing the temperature 2°C/day from ambient to the
maintenance temperature (6°C) using rodent incubators in the vi-
varium.Male mice (age 8 wk) were fed a chow diet (Purina IsoPro
3000) or a high-fat diet (Bio-Serv S3282) (Han et al. 2013). Whole-
body fat and lean mass were noninvasively measured by 1H-MRS
(Echo Medical Systems). The studies were approved by the Ani-
mal Care and Use Committees of the University of Massachu-
setts Medical School, Yale Medical School, and the University
of Cincinnati.
Genotype analysis
Genomic DNA was genotyped using a PCR-based method. The
amplimers 5′-GGACCCCTGAACTTGCTTCAC-3′, 5′-TTCAA
TTCCCAGCACCCACAGTAA-3′, and 5′-GGCTACCCGTGAT
ATTGCTGAAGAG-3′ were used to detected the AdipoqWT
(214-bp) and AdipoqΔ (520-bp) alleles. Cre+ (450 bp) was detected
using amplimers 5′- TTACTGACCGTACACCAAATTTGCCT
GC-3′ and 5′-CCTGGCAGCGATCGCTATTTTCCATGAG
TG-3′. The amplimers 5′-CCTGACTCTTCCTGAATC-3′ and
5′-GAGCCCAAAATGGTG-3′ were used to detect the Fgf21WT
(216-bp) and Fgf21LoxP (288-bp) alleles. The amplimers 5′-GCC
AAGTGTCAGAACTG-3′ and 5′-CCGTGGTACCAGGAAT
GC-3′ were used to detect the Fgf21LoxP (1211-bp) and Fgf21Δ
(298-bp) alleles. The amplimers 5′- CCTCAGGAAGAAAGGGC
TTATTTC-3′ and 5′-GAACCACTGTTCCAATTTCCATCC-3′
detected the Mapk8WT allele (1550 bp), the Mapk8LoxP allele
(1095 bp), and the Mapk8Δ allele (395 bp). The amplimers 5′-GT
TTTGTAAAGGGAGCCGAC-3′ and 5′-CCTGACTACTGAGC
CTGGTTTCTC-3′ were used to detect the Mapk9WT allele (224
bp) and the Mapk9LoxP allele (264 bp). The amplimers 5′-
GGAATGTTTGGTCCTTTAG-3′, 5′-GCTATTCAGAGTTAA
GTG-3′, and 5′-TTCATTCTAAGCTCAGACTC-3′ were used to
detect the Mapk9LoxP allele (560 bp) and the Mapk9Δ allele (400
bp). The amplimers were obtained from Eurofins Genomics LLC.
AAV transduction studies
High-titer AAV8-TBG-Cre stocks were prepared using plasmid
AAV.TBG.PI.Cre.rBG (Addgene plasmid 107787; RRID: Addg-
ene_107787) by the University of Massachusetts Medical School
Viral Vector Core. Mice were injected intravenously with 1.5 ×
1011 genome copies of AAV8 vector per mouse.
RNA analysis
The expression of mRNA and microRNA were examined by
quantitative PCR analysis using a Quantstudio PCR machine
(Thermo Fisher Scientific) andTaqMan probes (Supplemental Ta-
ble S2). Fgf21 mRNA expression was measured using Thermo
Fisher TaqMan probes (Supplemental Table S2) in studies of
Fgf21+/+ cells and mice. Studies of Fgf21 mRNA expression in
mice with floxed Fgf21 alleles were performed using Universal
ProbeLibrary Probe 67 (Roche, Cat# 4688651001) and amplimers
5′-AGATGGAGCTCTCTATGGATCG-3′ and 5′-GGGCTTCA
GACTGGTACACAT-3′ (Eurofins Genomics LLC). Normalized
relative mRNA and microRNA expression was performed by
measurement of the amount of 18S RNA and U6 RNA, respec-
tively, in each sample.
Insulin treatment
Intraperitoneal injection of mice with saline (control) or 1 U/kg
insulin (15min) was performed. Tissue extracts were prepared us-
ing Triton lysis buffer (20 mM Tris at pH 7.4, 1% Triton X-100,
10% glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM β-glycero-
phosphate, 1 mM sodium orthovanadate, 1 mM phenylmethyl-
sulfonyl fluoride, 10 µg/mL aprotinin plus leupeptin).
Immunoblot analysis
Extracts (20–50 µg of protein) were examined by protein immuno-
blot analysis by probing with antibodies to AKT (Cell Signaling
Technology 9272; RRID: AB_329827), pSer473 AKT (Cell Signal-
ing Technology 9271; RRID: AB_329825), pThr308 AKT (Cell Sig-
naling Technology 4056; RRID: AB_331163), JNK1/2 (BD
Biosciences 554285, RRID: AB_395344), GAPDH (Santa Cruz
Biotechnology sc-25778, RRID: AB_10167668), and αTubulin
(clone B-5-1-2; Millipore-Sigma T5168; :RRID: 477579). IRDye
680LT-conjugated donkey anti-mouse immunoglobulin G (IgG)
antibody (LI-COR Biosciences 926-68022, RRID: AB_10715072)
and IRDye 800CW conjugated-goat anti-rabbit IgG (LI-COR Bio-
sciences 926-32211, RRID: AB_621843) were used to detect and
quantitate immune complexes with the Odyssey infrared imag-
ing system (LI-COR Biosciences).
Measurement of blood glucose and adipokine concentration
Blood glucose was measured with an Ascensia Breeze 2 glucome-
ter (Bayer). Insulin, IL6, and leptin in plasma were measured by
multiplexed ELISA (Millipore Sigma MMHMAG-44K) using a
Luminex 200 machine (Millipore Sigma). The plasma concentra-
tion of FGF21 (Millipore Sigma EZRMFGF21-26K) and adiponec-
tin (Millipore Sigma EZMADP-60K) was measured by ELISA.
Measurement of hepatic triglyceride
Liver triglyceride was measured using a kit (Millipore Sigma
TR0100).
Hyperinsulinemic-euglycemic clamp studies
Basal infusion and hyperinsulinemic-euglycemic clamp studies
were performed after an overnight fast to assess whole-body, he-
patic, and adipose tissue insulin sensitivity (Perry et al. 2015).
Glucose, pyruvate, and insulin tolerance tests
Glucose, pyruvate, and insulin tolerance tests were performed us-
ing methods described previously (Sabio et al. 2008).
Glucose-induced insulin release
Glucose-stimulated insulin secretion (GSIS) measurements were
performed by intraperitoneal injection of glucose (2 g/kg) and
measurement of blood insulin concentration at 0, 5, and 15 min.
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Body temperature
Biocompatible and sterile microchip transponders (IPTT-300 ex-
tended accuracy calibration; Bio Medic Data Systems) were im-
planted and core body temperature was measured by telemetry.
Thermal imaging was performed using an infrared thermal cam-
era (FLIR-T62101) and analyzed with FLIR Tools software.
Metabolic cages
The analysis was performed by the Mouse Metabolic Phenotyp-
ing Center at theUniversity of Cincinnati. Themicewere housed
under controlled temperature and lighting with free accesses to
food and water. Respiratory exchange ratio and energy exchange
ratio were measured using metabolic cages.
Analysis of tissue sections
Histology was performed using tissue fixed in 10% formalin for
24 h, dehydrated, and embedded in paraffin. Sections (5 µm)
were cut and stained using hematoxylin and eosin (American
Master Tech Scientific). Adipocyte size and number were as-
sessed using H&E-stained sections with Image J software. Immu-
nohistochemistry was performed using deparaffinized tissue
sections that were incubated in blocking buffer for 1 h (1%
BSA, 10% normal goat serum in PBS) and permeabilized with
0.1%Triton X-100. The sectionswere incubated in blocking buff-
er containing primary antibodies to insulin (Agilent A0564,
RRID: AB_10013624), glucagon (Abcam ab10988, RRID:
AB_2917642), and UCP1 (Abcam ab10983, RRID: AB_2241462).
The insulin antibody was detected using Alexa-Fluor 488 conju-
gated-goat anti-guinea pig IgG (H+L) antibody (Thermo Fisher
Scientific A-11073, RRID: AB_2534117), the glucagon antibody
was detected using Alexa Fluor 546 conjugated-donkey anti-
mouse IgG (H+L) antibody (Thermo Fisher Scientific A-10036,
RRID: AB_2534012), and the UCP1 antibody was detected using
Alexa Fluor 488-conjugated goat anti-rabbit IgG (H+L) antibody
(Thermo Fisher Scientific A-11034, RRID: AB_2576217). DNA
was detected by staining with DAPI (Thermo Fisher Scientific
D3571, RRID: AB_2307445). Fluorescence was visualized using
a Leica TCS SP2 confocal microscope equipped with a 405-nm
diode laser. Islet area was determined by dividing total β-cell
area (marked by stainingwith insulin antibodies) by the pancreat-
ic area per section.
Adipocyte and stromal vascular cell isolation
The stromal vascular cell fraction (SVF) of white fat (EpiF) was
isolated (Herrero et al. 2010). Briefly, EpiF was excised and
minced into 10 mL of KRB solution (12.5 mM HEPES at pH 7.4,
120 mM NaCl, 6 mM KCl, 1.2 mM MgSO4, 1 mM CaCl2, 2%
BSA, 2.5 mM glucose). Collagenase II (1 mg/mL; Millipore Sigma
C6885) and DNase I (0.2 mg/mL; Millipore Sigma DN-25) were
added and the tissue was incubated at 37°C with shaking (40
min). Larger particles were removed using a 100-µm nylon sieve
and the filtrateswere centrifuged at 1000 rpm (3min). Floating ad-
ipocytes were washed twice with phosphate-buffered saline (PBS)
prior to RNA isolation.Nonadipocyte layers (SVF)were collected,
centrifuged at 3000 rpm (5 min), and washed with PBS.
Statistical analysis
Data are presented as the mean and standard error. Statistical
analysis was performed using GraphPad Prism version 7 (Graph-
Pad Software). ANOVA with Bonferroni’s test was used to deter-
mine significance with an assumed confidence interval of 95%.
Two-tailed, unpaired t-test with Welch’s correction was used
for pairwise comparisons. Statistical significance was defined as
P<0.05.
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